What's the outlook for ASX healthcare shares in Q2?

Here are some of the numbers looking ahead.

| More on:
A doctor appears shocked as he looks through binoculars on a blue background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX healthcare shares have been underwhelming this year
  • Projections for the industry are a little more optimistic, with some of the larger players looking to secure gains
  • We've crunched the numbers to see what's on the horizon for the industry

ASX healthcare shares have been a mixed bag in 2022. The industry was flourishing during the later part of the last calendar year but took a turn as early as November.

The downside continued along with the broader sell-off in equities. However, unlike most other industries, it has failed to reclaim a good portion of the losses.

The S&P/ASX 200 Health Care Index (ASX: XHJ) is down more than 10% this year to date and is sitting around the same over the past 12 months.

What are the projections?

Healthcare is seen as a 'defensive' industry that is largely insensitive to the business cycle. With this in mind, the current and forward-looking economic climate are of interest to those looking at ASX healthcare shares.

The industry trades on a price-to-earnings (P/E) ratio of 30.09 times at the time of writing, and has delivered a trailing dividend yield of 1.62%.

Some of the largest players, such as CSL Limited (ASX: CSL), Resmed Inc (ASX: RMD), and Sonic Healthcare Limited (ASX: SHL), reside within this portion of the market.

Each of these dominant names has numerous bullish price targets that point to strength in the industry across a diverse array of services.

CSL is rated a buy from 13 out of 16 brokers covering the share, with a $320 consensus price target (all data sourced from Refinitiv Eikon). The CSL share price closed on Friday at $280.43.

Meanwhile, Resmed is also tipped as a buy from nine out of 14 analysts, with a consensus valuation of $36.10. Resmed shares ended Friday's session trading for $34.14 apiece.

Sonic is rated a buy from six out of the 15 analysts covering it, with a $35.86 price target assigned. The Sonic share price is $30.55 as of Friday's close.

Noteworthy is that each consensus price target is priced above the current market value of each share.

In addition, some of the largest ASX healthcare shares are posted in the table below, with their respective fundamentals. All figures are in millions of dollars (except earnings per share and percentage).

NameRevenue [$million]EBITDANet IncomeEPSFree Cash FlowROE (%)
S&P/ASX 200 Health Care Index (ASX: XHJ)1,992.3514.4281.6 $     0.8898.816.3
CSL Limited (ASX: CSL)15,304.95534.73267.2 $     6.97740.219.6
Resmed Inc (ASX: RMD)5,185.01683.51129.5 $     7.68779.125.0
Sonic Healthcare Limited (ASX: SHL)9,340.22835.81460.6 $     3.021356.921.4
Ramsay Health Care Limited (ASX: RHC)13,210.21334.1274.0 $     1.16229.36.9
Cochlear Limited (ASX: COH)1,648.3471.2289.1 $     4.4095.117.1
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)15,58.9557.7349.4 $     0.6072.523.6
Pro Medicus Limited (ASX: PME)94.169.344.4 $     0.4223.948.5
Ansell Limited (ASX: ANN)2,828.7470.9230.0 $     1.79102.610.3
Healius Ltd (ASX: HLS)2,336.2766.9307.9 $     0.52380.915.6
Telix Pharmaceuticals Ltd (ASX: TLS)7.6-71.8-80.5 $   (0.29)-76.7-198.4
Imugene Limited (ASX: IMU)0.0-35.3-37.9 $   (0.01)-35.7-37.2
Nanosonics Ltd (ASX: NAN)120.37.63.7 $     0.012.52.7

With that, we can observe some names from the above list with projected earnings over the next two years in the table below as well.

 EPS   
NamePrevThis yearFY24FY25
S&P/ASX 200 Health Care (GIC) $   1.32 $   0.86 $   1.18 $   1.56
Resmed Inc $   4.32 $   7.68 $   8.47 $   9.46
CSL Ltd $   6.94 $   6.97 $   8.56 $ 10.40
Cochlear Ltd $   4.97 $   4.40 $   5.31 $   6.65
Sonic Healthcare Ltd $   2.73 $   3.02 $   1.72 $   1.56
Ansell Ltd $   2.53 $   1.79 $   2.23 $   2.09
Ramsay Health Care Ltd $   1.80 $   1.13 $   2.98 $   3.13
Fisher & Paykel Healthcare Corporation Ltd $   0.83 $   0.60 $   0.64 $   0.74
Healius Ltd $   0.11 $   0.50 $   0.21 $   0.22
Pro Medicus Ltd $   0.29 $   0.42 $   0.54 $   0.65
Nanosonics Ltd $   0.03 $   0.01 $   0.09 — 
Imugene Ltd $ (0.00) $ (0.01) $ (0.01) $ (0.01)
Telix Pharmaceuticals Ltd $ (0.17) $ (0.29) $ (0.30) $ (0.03)

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »